# The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma

> **NCT05144087** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 18 (estimated)

## Conditions studied

- Asthma; Eosinophilic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05144087
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-25
- **Primary completion:** 2024-05-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144087, "The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05144087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*